Despite the robust role of BMPR2 in PAH, specific pharmacological or biotherapeutic alternatives to fully restore its lung EC-mediated canonical signaling remain challenging, especially when translating findings from rodent animal models into the complexities of human patients’ physiology. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.